Nomogram update to predict the high genomic risk breast cancer by different races
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nomogram update to predict the high genomic risk breast cancer by different races
Authors
Keywords
-
Journal
Clinical Breast Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-22
DOI
10.1016/j.clbc.2023.10.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity
- (2022) Jaleesa Moore et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US Women
- (2021) Kent F. Hoskins et al. JAMA Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age
- (2021) Jing Yu et al. Journal of Translational Medicine
- Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
- (2021) Wanjing Chen et al. World Journal of Surgical Oncology
- Identifying Clinicopathological Factors Associated with Oncotype DX® 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada
- (2021) Simon Gagnet et al. Journal of Personalized Medicine
- Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States
- (2021) Guan-Qiao Li et al. Clinical Breast Cancer
- 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
- (2021) Kevin Kalinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer
- (2020) Yunan Han et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Distribution and Short‐term Prognostic Value of the 21‐gene recurrence score in African American compared to White American breast cancer patients
- (2019) Ali Amro et al. Breast Journal
- Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data
- (2019) Amila Orucevic et al. BREAST
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma
- (2018) Jing Li Huang et al. BREAST CANCER RESEARCH AND TREATMENT
- Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
- (2016) Amila Orucevic et al. BREAST CANCER RESEARCH AND TREATMENT
- Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor–positive, human epidermal growth factor receptor 2–negative early-stage breast cancer
- (2016) Joan Albanell et al. EUROPEAN JOURNAL OF CANCER
- Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer
- (2016) Hyun-seok Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
- (2015) Lillian Smyth et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
- (2015) Lindsey Enewold et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
- (2015) Bradley M Turner et al. MODERN PATHOLOGY
- Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
- (2012) Nathan W. D. Lamond et al. BREAST CANCER RESEARCH AND TREATMENT
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started